TSGA10IP
gene geneOn this page
Also known as FLJ32880FAM161C
Summary
TSGA10IP (testis specific 10 interacting protein, HGNC:26555) is a protein-coding gene on chromosome 11q13.1, encoding Testis-specific protein 10-interacting protein (Q3SY00).
Predicted to be involved in cilium organization. Predicted to be located in cytoskeleton. Predicted to be active in photoreceptor connecting cilium.
Source: NCBI Gene 254187 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 109 total
- MANE Select transcript:
NM_152762
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26555 |
| Approved symbol | TSGA10IP |
| Name | testis specific 10 interacting protein |
| Location | 11q13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32880, FAM161C |
| Ensembl gene | ENSG00000175513 |
| Ensembl biotype | protein_coding |
| Entrez | 254187 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding
ENST00000528291, ENST00000531518, ENST00000532620, ENST00000534740, ENST00000608857
RefSeq mRNA: 6 — MANE Select: NM_152762
NM_001395491, NM_001395492, NM_001395493, NM_001395494, NM_001395495, NM_152762
CCDS: CCDS66138
Canonical transcript exons
ENST00000532620 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001190213 | 65953567 | 65953737 |
| ENSE00001190216 | 65948001 | 65948148 |
| ENSE00001190228 | 65946880 | 65947016 |
| ENSE00002144525 | 65959190 | 65959314 |
| ENSE00002274099 | 65958883 | 65958982 |
| ENSE00003740938 | 65947110 | 65947828 |
| ENSE00003978213 | 65959817 | 65959966 |
| ENSE00003978214 | 65945480 | 65945822 |
Expression profiles
Bgee: expression breadth broad, 74 present calls, max score 82.43.
Top tissues by expression
200 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.43 | silver quality |
| left testis | UBERON:0004533 | 75.74 | gold quality |
| buccal mucosa cell | CL:0002336 | 74.22 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.19 | gold quality |
| right testis | UBERON:0004534 | 73.54 | gold quality |
| testis | UBERON:0000473 | 72.38 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 69.01 | gold quality |
| parotid gland | UBERON:0001831 | 66.09 | gold quality |
| myocardium | UBERON:0002349 | 63.41 | gold quality |
| secondary oocyte | CL:0000655 | 60.70 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 60.00 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 58.56 | gold quality |
| heart right ventricle | UBERON:0002080 | 58.50 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 58.15 | gold quality |
| biceps brachii | UBERON:0001507 | 58.15 | gold quality |
| medial globus pallidus | UBERON:0002477 | 57.62 | gold quality |
| thyroid gland | UBERON:0002046 | 57.36 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 57.33 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 56.71 | gold quality |
| cerebellar cortex | UBERON:0002129 | 56.44 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 56.37 | gold quality |
| granulocyte | CL:0000094 | 56.19 | gold quality |
| cerebellum | UBERON:0002037 | 55.97 | gold quality |
| monocyte | CL:0000576 | 55.85 | gold quality |
| leukocyte | CL:0000738 | 55.79 | gold quality |
| parietal pleura | UBERON:0002400 | 55.62 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 55.25 | gold quality |
| visceral pleura | UBERON:0002401 | 55.23 | gold quality |
| globus pallidus | UBERON:0001875 | 54.97 | gold quality |
| vastus lateralis | UBERON:0001379 | 54.70 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.96 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tsga10ip | ENSMUSG00000039330 |
| rattus_norvegicus | Tsga10ip | ENSRNOG00000027564 |
| caenorhabditis_elegans | WBGENE00012626 |
Paralogs (2): FAM161B (ENSG00000156050), FAM161A (ENSG00000170264)
Protein
Protein identifiers
Testis-specific protein 10-interacting protein — Q3SY00 (reviewed: Q3SY00)
Alternative names: Tsga10-interacting protein
All UniProt accessions (3): Q3SY00, A0A087WZG0, A0A087X0H3
UniProt curated annotations — full annotation on UniProt →
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q3SY00-1 | 1 | yes |
| Q3SY00-2 | 2 |
RefSeq proteins (6): NP_001382420, NP_001382421, NP_001382422, NP_001382423, NP_001382424, NP_689975* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR051655 | FAM161 | Family |
UniProt features (19 total): region of interest 5, sequence variant 5, compositionally biased region 4, splice variant 2, chain 1, sequence conflict 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3SY00-F1 | 58.35 | 0.19 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 19 (showing top):
chr11q13, GOBP_CILIUM_ORGANIZATION, GOCC_NEURON_PROJECTION, GOBP_CELL_PROJECTION_ORGANIZATION, GOCC_CILIARY_TRANSITION_ZONE, GOCC_PHOTORECEPTOR_CONNECTING_CILIUM, GOCC_CILIUM, GOCC_NON_MOTILE_CILIUM, GOCC_9PLUS0_NON_MOTILE_CILIUM, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOCC_PHOTORECEPTOR_CELL_CILIUM, GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP, GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN, GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN, GTTRYCATRR_UNKNOWN
GO Biological Process (1): cilium organization (GO:0044782)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytoskeleton (GO:0005856), photoreceptor connecting cilium (GO:0032391)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| organelle organization | 1 |
| plasma membrane bounded cell projection organization | 1 |
| binding | 1 |
| intracellular membraneless organelle | 1 |
| ciliary transition zone | 1 |
| photoreceptor cell cilium | 1 |
Protein interactions and networks
STRING
424 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TSGA10IP | OR5M9 | Q8NGP3 | 612 |
| TSGA10IP | OR10AG1 | Q8NH19 | 601 |
| TSGA10IP | PIGZ | Q86VD9 | 564 |
| TSGA10IP | ABCC12 | Q96J65 | 522 |
| TSGA10IP | ENTHD1 | Q8IYW4 | 473 |
| TSGA10IP | ZNF438 | Q7Z4V0 | 419 |
| TSGA10IP | TSKS | Q9UJT2 | 400 |
| TSGA10IP | H0YL38 | H0YL38 | 392 |
| TSGA10IP | NPAP1 | Q9NZP6 | 387 |
| TSGA10IP | ZNF280D | Q6N043 | 379 |
| TSGA10IP | AMER3 | Q8N944 | 375 |
| TSGA10IP | CCDC69 | A6NI79 | 370 |
| TSGA10IP | SPAG5 | Q96R06 | 363 |
| TSGA10IP | TSPAN11 | A1L157 | 350 |
| TSGA10IP | SLX4 | Q8IY92 | 347 |
IntAct
358 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP70 | TSGA10IP | psi-mi:“MI:0915”(physical association) | 0.780 |
| TSGA10IP | CEP70 | psi-mi:“MI:0915”(physical association) | 0.780 |
| MTUS2 | TSGA10IP | psi-mi:“MI:0915”(physical association) | 0.670 |
| TSGA10IP | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TRIM27 | TSGA10IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC57 | TSGA10IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | CCDC57 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | AMOTL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NAB2 | TSGA10IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CALCOCO2 | TSGA10IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | CCDC120 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | CARD9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | GRIPAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF2 | TSGA10IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | CAVIN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | ROPN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSGA10IP | CFL1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (158): TSGA10IP (Two-hybrid), TSGA10IP (Two-hybrid), TSGA10IP (Two-hybrid), TSGA10IP (Two-hybrid), CCDC57 (Two-hybrid), BRCA1 (Two-hybrid), NAA16 (Affinity Capture-MS), CUL2 (Affinity Capture-MS), ZYG11B (Affinity Capture-MS), YBEY (Affinity Capture-MS), DCAF5 (Affinity Capture-MS), NAA10 (Affinity Capture-MS), NAA50 (Affinity Capture-MS), HYPK (Affinity Capture-MS), CST4 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LP49, A0A8V8TNH8, A0A8V8TPE2, A2VE02, A5D7I0, A6NDY2, A6NGG8, A6NIJ5, A6NNJ1, A8MXJ8, A8MYA2, B1ASB6, B2RW88, D6RGX4, O60269, P0C7V4, P0C7W8, P0C7W9, P0C7X0, P0DV75, P0DV76, Q2KIS6, Q2NL68, Q3SY00, Q4R736, Q4V8B5, Q5RCQ2, Q5SZB4, Q5VZ46, Q5XIK6, Q658T7, Q66JV7, Q6NS69, Q6PAC4, Q6ZMY3, Q76N32, Q7TSA6, Q7Z591, Q80VW7, Q80X53
Diamond homologs: A5D7I0, Q3B820, Q3SY00, Q66MI6, Q8CB59
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
109 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 101 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1330 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:65947015:GA:G | donor_gain | 1.0000 |
| 11:65947017:G:GG | donor_gain | 1.0000 |
| 11:65953734:TGAGG:T | donor_loss | 1.0000 |
| 11:65953735:GAGGT:G | donor_loss | 1.0000 |
| 11:65953737:GGT:G | donor_loss | 1.0000 |
| 11:65953738:GTAG:G | donor_loss | 1.0000 |
| 11:65953739:T:G | donor_loss | 1.0000 |
| 11:65947012:GAAGA:G | donor_gain | 0.9900 |
| 11:65947108:A:AG | acceptor_gain | 0.9900 |
| 11:65947109:G:GG | acceptor_gain | 0.9900 |
| 11:65948138:G:GT | donor_gain | 0.9900 |
| 11:65948148:GGTAA:G | donor_loss | 0.9900 |
| 11:65948149:G:GC | donor_loss | 0.9900 |
| 11:65948150:T:A | donor_loss | 0.9900 |
| 11:65953560:A:AG | acceptor_gain | 0.9900 |
| 11:65953561:C:G | acceptor_gain | 0.9900 |
| 11:65953564:A:AG | acceptor_gain | 0.9900 |
| 11:65953564:AAG:A | acceptor_gain | 0.9900 |
| 11:65953565:A:G | acceptor_gain | 0.9900 |
| 11:65953566:G:A | acceptor_gain | 0.9900 |
| 11:65953566:GG:G | acceptor_loss | 0.9900 |
| 11:65953566:GGA:G | acceptor_gain | 0.9900 |
| 11:65958881:A:AG | acceptor_gain | 0.9900 |
| 11:65958882:G:GG | acceptor_gain | 0.9900 |
| 11:65958974:GC:G | donor_gain | 0.9900 |
| 11:65958978:TGCAG:T | donor_loss | 0.9900 |
| 11:65958979:GCAGG:G | donor_loss | 0.9900 |
| 11:65958980:CAGGT:C | donor_loss | 0.9900 |
| 11:65958981:AGGT:A | donor_loss | 0.9900 |
| 11:65958982:GG:G | donor_loss | 0.9900 |
AlphaMissense
3578 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:65959220:T:C | F485L | 0.986 |
| 11:65959222:C:A | F485L | 0.986 |
| 11:65959222:C:G | F485L | 0.986 |
| 11:65958966:T:C | F469S | 0.985 |
| 11:65958965:T:C | F469L | 0.984 |
| 11:65958967:C:A | F469L | 0.984 |
| 11:65958967:C:G | F469L | 0.984 |
| 11:65959221:T:C | F485S | 0.983 |
| 11:65947147:T:C | F108L | 0.982 |
| 11:65947149:C:A | F108L | 0.982 |
| 11:65947149:C:G | F108L | 0.982 |
| 11:65958966:T:G | F469C | 0.981 |
| 11:65947141:T:C | F106L | 0.978 |
| 11:65947143:C:A | F106L | 0.978 |
| 11:65947143:C:G | F106L | 0.978 |
| 11:65947155:G:C | W110C | 0.978 |
| 11:65947155:G:T | W110C | 0.978 |
| 11:65948131:A:C | K378N | 0.977 |
| 11:65948131:A:T | K378N | 0.977 |
| 11:65947153:T:A | W110R | 0.973 |
| 11:65947153:T:C | W110R | 0.973 |
| 11:65947161:G:C | W112C | 0.972 |
| 11:65947161:G:T | W112C | 0.972 |
| 11:65958974:G:C | A472P | 0.971 |
| 11:65958912:A:C | Y451S | 0.970 |
| 11:65947159:T:A | W112R | 0.969 |
| 11:65947159:T:C | W112R | 0.969 |
| 11:65958911:T:C | Y451H | 0.969 |
| 11:65958924:T:C | L455P | 0.968 |
| 11:65958933:T:C | I458T | 0.967 |
dbSNP variants (sampled 300 via entrez): RS1000018081 (11:65944490 T>C), RS1000094545 (11:65953449 G>C,T), RS1000240798 (11:65957007 G>A), RS1000488526 (11:65955536 C>T), RS1000495894 (11:65944187 G>A), RS1000629565 (11:65949947 G>C), RS1000700395 (11:65954620 C>A,T), RS1000733982 (11:65955838 G>T), RS1001074289 (11:65945986 T>C), RS1001195272 (11:65944873 G>A), RS1001554123 (11:65956436 C>T), RS1001589559 (11:65950855 C>A,T), RS1001657459 (11:65950313 A>G), RS1001669351 (11:65944547 C>A,T), RS1001702928 (11:65957745 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002481_8 | Acne (severe) | 3.000000e-11 |
| GCST003123_24 | Severe influenza A (H1N1) infection | 3.000000e-17 |
| GCST007294_7 | Body fat distribution (trunk fat ratio) | 8.000000e-12 |
| GCST007294_75 | Body fat distribution (trunk fat ratio) | 1.000000e-07 |
| GCST007295_158 | Body fat distribution (leg fat ratio) | 8.000000e-06 |
| GCST007295_48 | Body fat distribution (leg fat ratio) | 3.000000e-09 |
| GCST008972_130 | Urate levels | 2.000000e-271 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:1001488 | influenza A (H1N1) |
| EFO:0004341 | body fat distribution |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Triclosan | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.